Brief: Catabasis Pharmaceuticals Reports Q1 Loss Per Share $7.60

Astria Therapeutics

13/05/2021 21:14

May 13 (Reuters) - Catabasis Pharmaceuticals Inc  CATB.O :
    * CATABASIS PHARMACEUTICALS REPORTS FIRST QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES A CORPORATE UPDATE
    * Q1 LOSS PER SHARE $7.60
    * CATABASIS - ASSUMING APPROVAL OF PREFERRED STOCK
CONVERSION,
EXPECTS IT HAS SUFFICIENT CASH TO FUND CURRENT OPERATING PLAN
THROUGH 2023

Source text for Eikon:  ID:nBw2Wwh5qa 
Further company coverage:  CATB.O 

 ((Reuters.Briefs@thomsonreuters.com;))